Structure Therapeutics Inc. American Depositary Shares Earnings

The next earnings date for Structure Therapeutics Inc. American Depositary Shares is November 12, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Structure Therapeutics Inc. American Depositary Shares Earnings

Report DateEstimated Earnings Per Share
11/12/2025$-0.27

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Structure Therapeutics Inc. American Depositary Shares Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/07/2025---$-0.36-38.46%
05/12/2025---$-0.27-16.93%
11/15/2024---$-0.20-7.12%
08/09/2024---$-0.1820.00%
05/09/2024After Market$-0.199.52%
03/08/2024Before Market$-0.53-153.14%
11/14/2023After Market$-0.62-113.79%
08/10/2023After Market$-0.60-114.29%
05/11/2023After Market$-0.2539.02%
03/31/2023After Market$-1.14-39.02%

More About Structure Therapeutics Inc. American Depositary Shares

Country
USA
Full Time Employees
199

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions. The company also develops ACCG-2671, which is in preclinical trial to treat obesity; ANPA-0073, an oral small molecule agonist targeting the apelin, which is phase 2 ready for selective weight loss or muscle-sparing weight loss; and LTSE-2578, an antagonist that targets lysophosphatidic acid 1 receptor, a G-protein coupled receptors implicated in responses to tissue injury and pro-fibrotic processes, for the treatment of idiopathic pulmonary fibrosis. In addition, it develops programs, including glucose-dependent insulinotropic polypeptide receptor (GIPR) program, which identified multiple GIPR agonist, dual GLP-1R/GIPR agonist, and GIPR antagonist hits for small molecule GIPR modulation that has the potential to provide a treatment in obesity; and GCG program, which identified multiple GCG receptor (GCGR) agonist and dual GLP-1R/GCGR agonist hits for small molecule GCGR modulation. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Structure Therapeutics Inc. American Depositary Shares Earnings” Can Refer to the Structure Therapeutics Inc. American Depositary Shares Earnings Date

Some people say “Structure Therapeutics Inc. American Depositary Shares earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Structure Therapeutics Inc. American Depositary Shares position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Structure Therapeutics Inc. American Depositary Shares Stock on the Earnings Date

If you own Structure Therapeutics Inc. American Depositary Shares stock (GPCR) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Structure Therapeutics Inc. American Depositary Shares might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Structure Therapeutics Inc. American Depositary Shares shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Structure Therapeutics Inc. American Depositary Shares Earnings

You can contact us any time if you would like to ask questions about Structure Therapeutics Inc. American Depositary Shares earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.